We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
England annual data on coverage achieved by the childhood immunisation programme.
Guidance relating to blood clotting, myocarditis and Guillain-Barré Syndrome (GBS) after COVID-19 vaccination.
VDEC’s Discovery and surveillance capabilities provide unique services across a spectrum of molecular immunology platforms.
The pre-clinical evaluation team at VDEC provides a safe and controlled environment to test new vaccines and therapeutics before they progress to clinical trials
Latest developments in vaccines, vaccination policies and procedures for immunisation practitioners.
People at greatest risk of serious illness from COVID-19 are eligible for a vaccine.
First published during the 2022 to 2024 Sunak Conservative government
The deal is set to boost pandemic preparedness against influenza.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).